Odyssey Therapeutics Inc.
ODTX | NASDAQ
$19.17
-$0.37 (-1.89%)
Nov 2, 2026, 12:05 PM ET · Market open
TTM Period Ending | TTM 2025 Dec 31, 2025 |
|---|---|
PE Ratio | -3.05 |
PEG Ratio | n/a |
PS Ratio | 152.07 |
PB Ratio | -0.93 |
P/FCF Ratio | -3.46 |
P/OCF Ratio | -3.50 |
OCF/S Ratio | -4.35K |
Debt / Equity Ratio | -0.06 |
Quick Ratio | 7.20 |
Current Ratio | 7.20 |
Asset Turnover | 0.01 |
Interest Coverage | -9.48K |
Return on Equity | 30.44% |
Return on Assets | -55.10% |
Return on Invested Capital | -64.44% |
Dividend Yield | n/a |
Payout Ratio | n/a |
FCF Payout Ratio | n/a |
Gross Profit Margin | 100% |
Net Profit Margin | -4.99K% |
Pretax Profit Margin | -5.03K% |
Operating Profit Margin | -5.42K% |
FCF Margin | -4.39K% |
EBITDA Margin | -4.86K% |
Add to Watchlist
Select watchlists to add or remove ODTX